$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$8.02M
Market Cap
-
P/E Ratio
-5.14
EPS
$12.54
52 Week High
$1.53
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
In8bio, Inc. is a New York-based clinical-stage biotechnology firm pioneering the development of innovative cancer therapies through genetically modified gamma-delta T cells. Focused on both autologous and allogeneic cell therapies, the company is strategically targeting solid tumors, thereby establishing itself as a key player in the immuno-oncology space. With a robust pipeline of proprietary treatments, In8bio is committed to meeting critical unmet needs in cancer care, aiming to deliver transformative solutions that could significantly alter the future of oncology therapeutics.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
INTC
TLRY
AVGO
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
MARA
PLTR
VALE
BAC
RR
WULF
SNAP
CLSK
DNN
APLT
IREN
PFE
BYND
IRBT
GOOGL
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
BITF
MTSR
FI
WBD
HOOD
JBLU
HL
QBTS
APLD
CAN
SOUN
CDE
T
AG
IVP
BTBT
NOK
SMR
EOSE
GOOG
LUV
TSM
BMY
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
INTC
TLRY
AVGO
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
MARA
PLTR
VALE
BAC
RR
WULF
SNAP
CLSK
DNN
APLT
IREN
PFE
BYND
IRBT
GOOGL
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
BITF
MTSR
FI
WBD
HOOD
JBLU
HL
QBTS
APLD
CAN
SOUN
CDE
T
AG
IVP
BTBT
NOK
SMR
EOSE
GOOG
LUV
TSM
BMY